Tüdőrák: vizsgálatok itt: Bosznia-Hercegovina
1 trial · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
- Where
- Banja Luka, Mostar, Sarajevo, Zenica
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07130916